Lipocine Inc. (LPCN)
NASDAQ: LPCN · Real-Time Price · USD
3.380
+0.035 (1.05%)
At close: May 30, 2025, 4:00 PM
3.370
-0.010 (-0.30%)
After-hours: May 30, 2025, 7:53 PM EDT
Lipocine Employees
Lipocine had 16 employees as of December 31, 2024. The number of employees decreased by 1 or -5.88% compared to the previous year.
Employees
16
Change (1Y)
-1
Growth (1Y)
-5.88%
Revenue / Employee
$229,677
Profits / Employee
-$335,634
Market Cap
18.08M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
LPCN News
- 9 days ago - Lipocine's LPCN 1148 Highlighted in the June 2025 Edition of Hepatology - PRNewsWire
- 17 days ago - Lipocine to Present at A.G.P.'s Annual Healthcare Company Showcase - PRNewsWire
- 23 days ago - Lipocine Announces Financial Results for the First Quarter Ended March 31, 2025 - PRNewsWire
- 25 days ago - Lipocine Announces License and Supply Agreement for TLANDO® in Brazil - PRNewsWire
- 2 months ago - Lipocine Announces Initiation of Outpatient Phase 3 Postpartum Depression Trial of LPCN 1154 - PRNewsWire
- 2 months ago - Lipocine Announces Financial Results for the Full Year Ended December 31, 2024 - PRNewsWire
- 2 months ago - Lipocine Announces FDA Labeling Changes for Testosterone Products - PRNewsWire
- 4 months ago - Lipocine Receives Updated Regulatory Guidance on LPCN 1154 - PRNewsWire